Literature DB >> 31577062

Effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood.

Marwa Awad Abdel Hamid Ibrahim1, Walaa M Elwan1.   

Abstract

Irinotecan is one of the most important anti-tumour drugs against a broad spectrum of malignancies, but is known to be associated with possible oral complications. The aim of the present study was to evaluate the effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood using different histological and immunohistochemical methods. Twenty juvenile male albino rats were divided equally into two groups: control and irinotecan-treated group (single injection of 200 mg irinotecan/kg, then kept for four weeks without treatment). The tongue specimens were processed for light microscopy and scanning electron microscopy. The irinotecan-treated group showed statistically significant shortening and thinning of the lingual papillae. There was loss of the normal appearance of the filiform papillae with focal cell loss alternating with areas of hyperkeratosis. Focal separation of the keratin layer, some nuclear changes and vacuolation of some epithelial cells were detected. Dilated congested blood vessels and mild mononuclear cellular infiltration were encountered. Atrophic fungiform papillae with ill-defined taste bud cells were observed. A statistically significant decrease in the pattern of Ki67 immunohistochemical staining reaction was detected in comparision to the control group. Scanning electron microscopy revealed different signs of atrophy of the tongue papillae. Focal areas of desquamation of lingual papillae were observed revealing some filiform papillae with desquamated surface, bisected tips and evident thinning. Some extravasated red blood cells could be detected. Thus irinotecan caused significant morphological and morphometrical alterations of the tongue mucosa in particularly the filiform papillae.
© 2019 The Authors. International Journal of Experimental Pathology © 2019 International Journal of Experimental Pathology.

Entities:  

Keywords:  Ki67; irinotecan; scanning electron microscopy; tongue

Mesh:

Substances:

Year:  2019        PMID: 31577062      PMCID: PMC6877997          DOI: 10.1111/iep.12333

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

Review 1.  Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions.

Authors:  Andrei Barasch; Douglas E Peterson
Journal:  Oral Oncol       Date:  2003-02       Impact factor: 5.337

Review 2.  Mechanisms for radiation-induced oral mucositis and the consequences.

Authors:  Aishan Shih; Christine Miaskowski; Marylin J Dodd; Nancy A Stotts; Laurie MacPhail
Journal:  Cancer Nurs       Date:  2003-06       Impact factor: 2.592

3.  Irinotecan chemotherapy-induced intestinal oxidative stress: Underlying causes of disturbed mucosal water and electrolyte transport.

Authors:  Kaïs Rtibi; Slimen Selmi; Dhekra Grami; Hichem Sebai; Mohamed Amri; Lamjed Marzouki
Journal:  Pathophysiology       Date:  2017-07-23

4.  Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.

Authors:  M Hejna; W J Köstler; M Raderer; G G Steger; T Brodowicz; W Scheithauer; C Wiltschke; C C Zielinski
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

Review 5.  Topoisomerase I inhibitors: topotecan and irenotecan.

Authors:  G J Creemers; B Lund; J Verweij
Journal:  Cancer Treat Rev       Date:  1994-01       Impact factor: 12.111

Review 6.  [Treatment and prevention of cancer treatment related oral mucositis].

Authors:  Gonzalo Ruiz-Esquide; Bruno Nervi; Alex Vargas; Alberto Maíz
Journal:  Rev Med Chil       Date:  2011-08-25       Impact factor: 0.553

7.  Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat.

Authors:  Noor Al-Dasooqi; Joanne M Bowen; Rachel J Gibson; Richard M Logan; Andrea M Stringer; Dorothy M Keefe
Journal:  Int J Exp Pathol       Date:  2011-04-05       Impact factor: 1.925

8.  Establishment of a single-dose irinotecan model of gastrointestinal mucositis.

Authors:  Rachel J Gibson; Joanne M Bowen; Enrique Alvarez; John Finnie; Dorothy M K Keefe
Journal:  Chemotherapy       Date:  2007-08-21       Impact factor: 2.544

Review 9.  A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.

Authors:  Melissa E Badowski
Journal:  Cancer Chemother Pharmacol       Date:  2017-08-05       Impact factor: 3.333

10.  Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors.

Authors:  Ronell Bologna-Molina; Adalberto Mosqueda-Taylor; Nelly Molina-Frechero; Ana-Dolores Mori-Estevez; Guillermo Sánchez-Acuña
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01
View more
  2 in total

1.  Effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood.

Authors:  Marwa Awad Abdel Hamid Ibrahim; Walaa M Elwan
Journal:  Int J Exp Pathol       Date:  2019-10-02       Impact factor: 1.925

2.  Study of the Possible Alleviated Role of Atorvastatin on Irinotecan-Induced Lingual Mucosal Damage: Histological and Molecular Study.

Authors:  Eetmad A Arafat; S M Abo El-Khair; A Z Elsamanoudy; Dalia A Shabaan
Journal:  Oxid Med Cell Longev       Date:  2021-09-30       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.